Xin‐En Huang
Jiangsu Cancer Hospital · 156 works · 3,991 citations · h-index 40
Top works
- Comparison of lifestyle risk factors by family history for gastric, breast, lung and colorectal cancer.
- Clarification of the APJCP Editorial Policy
- Comparison of Complications of Peripherally Inserted Central Catheters with Ultrasound Guidance or Conventional Methods in Cancer Patients
- Phase II Trial of Loubo®(Lobaplatin) and Pemetrexed for Patients with Metastatic Breast Cancer not Responding to Anthracycline or Taxanes
- Hepatitis B and C Viruses Infection, Lifestyle and Genetic Polymorphisms as Risk Factors for Hepatocellular Carcinoma in Haimen, China
- Clinical Comparison between Paclitaxel Liposome (Lipusu®) and Paclitaxel for Treatment of Patients with Metastatic Gastric Cancer
- Inhibition of Tumor Growth in Vitro by a Combination of Extracts from Rosa Roxburghii Tratt and Fagopyrum Cymosum
- Clinical Application of Serum Tumor Associated Material (TAM) from Non-small Cell Lung Cancer Patients
- Association ofp53 codon arg72pro andp73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of japanese breast cancer
- Clinical Safety and Efficacy of Kanglaite®(Coix Seed Oil) Injection Combined with Chemotherapy in Treating Patients with Gastric Cancer
- MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy.
- Clinical observations on safety and efficacy of OxyContin® administered by rectal route in treating cancer related pain.
- Weekly paclitaxel/ docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication.
- Comparison of Serum Tumor Associated Material (TAM) with Conventional Biomarkers in Cancer Patients
- Phase II trial of irinotecan plus nedaplatin (INP) in treating patients with extensive stage small cell lung cancer.
- Effect of Life Styles on the Risk of Sybsute-specific Gastric Cancer in Those with and without Family History
- Weekly TP regimen as a postoperative adjuvant chemotherapy for completely resected breast cancer in China: final result of a phase II trial.
- Clinical comparison of safety and efficacy of vinorelbine/epirubicin (NE) with fluorouracil/epirubicin/cyclophosphamide (FEC).
- Validation of treatment efficacy of a computer-assisted program for breast cancer patients receiving postoperative adjuvant chemotherapy.
- Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer.